Does ERIBULIN Cause Off label use? 101 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 101 reports of Off label use have been filed in association with ERIBULIN (eribulin mesylate). This represents 2.0% of all adverse event reports for ERIBULIN.
101
Reports of Off label use with ERIBULIN
2.0%
of all ERIBULIN reports
37
Deaths
51
Hospitalizations
How Dangerous Is Off label use From ERIBULIN?
Of the 101 reports, 37 (36.6%) resulted in death, 51 (50.5%) required hospitalization, and 1 (1.0%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ERIBULIN. However, 101 reports have been filed with the FAERS database.
What Other Side Effects Does ERIBULIN Cause?
Neutropenia (675)
Malignant neoplasm progression (594)
Myelosuppression (520)
Febrile neutropenia (448)
Neutrophil count decreased (294)
Neuropathy peripheral (290)
White blood cell count decreased (289)
Pyrexia (275)
Disease progression (211)
Fatigue (209)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which ERIBULIN Alternatives Have Lower Off label use Risk?
ERIBULIN vs ERLOTINIB
ERIBULIN vs ERTAPENEM
ERIBULIN vs ERTUGLIFLOZIN PIDOLATE
ERIBULIN vs ERYTHROMYCIN
ERIBULIN vs ERYTHROMYCIN ETHYLSUCCINATE